Usefulness of Platelet-to-Lymphocyte Ratio as a Marker of Sarcopenia for Critical Limb Threatening Ischemia.
Aged
Aged, 80 and over
Blood Platelets
Critical Illness
Female
Humans
Ischemia
/ blood
Lymphocyte Count
Lymphocytes
Male
Middle Aged
Peripheral Arterial Disease
/ blood
Platelet Count
Predictive Value of Tests
Reproducibility of Results
Retrospective Studies
Risk Assessment
Risk Factors
Sarcopenia
/ blood
Time Factors
Vascular Surgical Procedures
/ adverse effects
Journal
Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
15
04
2020
revised:
16
05
2020
accepted:
21
05
2020
pubmed:
2
6
2020
medline:
3
8
2021
entrez:
2
6
2020
Statut:
ppublish
Résumé
Sarcopenia is a factor of poor prognosis for patients with critical limb threatening ischemia (CLTI), but its diagnosis requires imaging measurements and is time consuming. We investigated whether preoperative platelet-to-lymphocyte ratio (PLR) could be an easy and rapid marker of sarcopenia. Patients treated for CLTI between January 2019 and July 2019 were included in this single-center retrospective study. Sarcopenia was defined by a psoas muscle index (PMI) <5.5 cm Sixty-four patients were included in the study: 48 nonsarcopenic patients (mean PMI 7.34 cm PLR might help identifying a subgroup of CTLI patients associated with poor prognosis but does not seem appropriate to be used as a marker of sarcopenia given its low sensitivity.
Sections du résumé
BACKGROUND
BACKGROUND
Sarcopenia is a factor of poor prognosis for patients with critical limb threatening ischemia (CLTI), but its diagnosis requires imaging measurements and is time consuming. We investigated whether preoperative platelet-to-lymphocyte ratio (PLR) could be an easy and rapid marker of sarcopenia.
METHODS
METHODS
Patients treated for CLTI between January 2019 and July 2019 were included in this single-center retrospective study. Sarcopenia was defined by a psoas muscle index (PMI) <5.5 cm
RESULTS
RESULTS
Sixty-four patients were included in the study: 48 nonsarcopenic patients (mean PMI 7.34 cm
CONCLUSIONS
CONCLUSIONS
PLR might help identifying a subgroup of CTLI patients associated with poor prognosis but does not seem appropriate to be used as a marker of sarcopenia given its low sensitivity.
Identifiants
pubmed: 32479878
pii: S0890-5096(20)30434-9
doi: 10.1016/j.avsg.2020.05.027
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
72-78Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.